Abstract

Human interleukin-10 (IL-10) is a potent anti-inflammatory cytokine that inhibits the synthesis of the major proinflammatory cytokines and chemokines. IL-10 is the principal TH2-type cytokine that upregulates humoral immune responses and attenuates cell-mediated immune reactions. This cytokine has a number of immunomodulatory properties that might be clinically useful in a variety of inflammatory and infectious disease states. Clinical trials with human recombinant IL-10 are already in progress. Carefully selected patients with inflammatory conditions may benefit from IL-10 therapy if concomitant infectious diseases are recognized and treated appropriately.

Keywords

MedicineImmunologyProinflammatory cytokineCytokineChemokineImmune systemInfectious disease (medical specialty)DiseaseInterleukinClinical trialInflammationInternal medicine

Affiliated Institutions

Related Publications

Publication Info

Year
1998
Type
review
Volume
27
Issue
6
Pages
1497-1507
Citations
115
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

115
OpenAlex

Cite This

Steven M. Opal, Janice C. Wherry, Paul Grint (1998). Interleukin‐10: Potential Benefits and Possible Risks in Clinical Infectious Diseases. Clinical Infectious Diseases , 27 (6) , 1497-1507. https://doi.org/10.1086/515032

Identifiers

DOI
10.1086/515032